JLP-1901
- Generic Name
- JLP-1901
To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT06171880
- Locations
- 🇰🇷
Bundang CHA university global clinical trials center Institutional Review Board, Gyeonggi-do, Bundang-gu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath